Tong Nuo Kang (同诺康)

China, China

Synnocare Pharmaceutical (南京同诺康医药科技有限公司) is a Chinese biotechnology and pharmaceutical company focused on developing innovative small-molecule drugs to address unmet clinical needs, particularly in areas such as cancer, autoimmune disorders, and central nervous system (CNS) diseases. The company integrates artificial intelligence and multi-omics technologies into its drug discovery and development process, spanning target identification, molecule design, and clinical trial planning. Its business model centers on creating original drugs with global IP rights, with potential commercialization through partnerships, licensing, and direct product development.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Tong Nuo Kang (同诺康) on @MedStartr Today #DrugDevelopment #Therapeutics #Biotech #MedMo #MedStartrVentures

https://www.medstartr.ai/s/LCTEKNcmMWw

Get Involved in Tong Nuo Kang (同诺康)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2021
Website: www.synnocare.com/

Technologies

Small Molecule DrugsDrug DevelopmentPharmaceutical Innovation

🌐Website

What do you think of Tong Nuo Kang (同诺康)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.